Pfizer to Invest $500M in State-of-the-Art Gene Therapy Facility in North Carolina

Shots:

• Pfizer plans to invest half-billion dollars for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina which is expected to support its ongoing R&D investments in gene therapy, like its R&D sites in Chapel Hill and Kit Creek
• The investment will expand Pfizer’s footprints in Sanford, strengthen its gene therapy manufacturing technology and its ability to develop both clinical- and commercial-scale quantities of gene therapies for patients with rare diseases across the globe
• Pfizer’s Sanford facility will manufacture gene therapies and its vaccine portfolio including Prevnar 13 and other vaccines currently present in Pfizer’s pipeline and will provide ~300 new jobs

Click here to­ read full press release/ article | Ref: Pfizer | Image: Behance